YAP1 and myocardial infarction: Genetic inhibition of fibroblast YAP alleviates cardiac dysfunction and fibrosis resulting from myocardial infarction,29 indicating that targeting YAP in fibroblasts holds promise as a therapeutic approach to prevent fibrotic remodeling and HF.